Here, we will describe the results of a study aiming for the simultaneous siRNA interference of MAPK and PI3K signaling pathways both downstream the EGFR receptor by a cetuximab-esiRNA carrier system in colorectal cancer in vitro and in vivo. This evidence concerns the gene PIK3CA and colorectal cancer.